Company profile
Oxford Investments Holdings Inc.
OTC: OXIHF · Healthcare · Medical - Pharmaceuticals
Canadian filerHQ Toronto, ONReports USD
#1072 of 1,418 Healthcare companies by revenuebottom-quartile growth
EA Score
——FH —DQ —GM —SS 33
v0.1 · 5/100 weight · pillars only
↑ listing tenure, return on assets · ↓ workforce scale, Piotroski F
Methodology →Revenue TTM
$7.2k
Rev growth YoY (TTM)
-90.6%
Net income (FY)
-$299.1k
Employees
1
as of 2026-08-28
Market cap
$72.0k
as of 2026-08-28
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$61.2k$61.2k2020
Net income-$299.1k-$299.1k2020
Operating income-$342.3k-$342.3k2020
Total assets$451.1k$451.1k2020
Liabilities$1.0M$1.0M2020
Equity-$473.8k-$473.8k2020
Revenue trend
FY2015 – FY2020 · USD
FY15
FY16
FY17
FY18
FY19
FY20
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Oxford Investments Holdings Inc.’s revenue?
Oxford Investments Holdings Inc. booked $61.2k in FY2020 revenue, contracting 81% year over year — slower than 88% of Healthcare companies we track, at a -489.0% net margin.
Peers · Healthcare
Inovio Pharmaceuticals, Inc.37DKali, Inc.——Connect Biopharma Holdings Limited25DReal Brands, Inc.——Avalo Therapeutics, Inc.41DMicro Imaging Technology, Inc.——Key facts
CEOMichael Donaghy
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersToronto, ON
ExchangeOTC: OXIHF
Employees1
IPO date2004-05-17
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.